Abstract
High-throughput profiling methods (such as genomics or imaging) have accelerated basic research and made deep molecular characterization of patient samples routine. These approaches provide a rich portrait of genes, molecular pathways and cell types involved in disease phenotypes. Machine learning (ML) can be a useful tool for extracting disease-relevant patterns from high-dimensional datasets. However, depending upon the complexity of the biological question, machine learning often requires many samples to identify recurrent and biologically meaningful patterns. Rare diseases are inherently limited in clinical cases, leading to few samples to study. In this Perspective, we outline the challenges and emerging solutions for using ML for small sample sets, specifically in rare diseases. Advances in ML methods for rare diseases are likely to be informative for applications beyond rare diseases for which few samples exist with high-dimensional data. We propose that the method community prioritize the development of ML techniques for rare disease research.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schaefer, J., Lehne, M., Schepers, J., Prasser, F. & Thun, S. The use of machine learning in rare diseases: a scoping review. Orphanet J. Rare Dis. 15, 145 (2020).
Decherchi, S., Pedrini, E., Mordenti, M., Cavalli, A. & Sangiorgi, L. Opportunities and challenges for machine learning in rare diseases. Front. Med. 8, 747612 (2021).
Li, A. et al. Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res. 69, 2091–2099 (2009).
Senate and House of Representatives of the United States of America in Congress. Orphan Drug Act (1983).
Agarwal, V. et al. Learning statistical models of phenotypes using noisy labeled training data. J. Am. Med. Inform. Assoc. 23, 1166–1173 (2016).
Frénay, B. & Verleysen, M. Classification in the presence of label noise: a survey. IEEE Trans. Neural Netw. Learn. Syst. 25, 845–869 (2014).
Toh, T. S., Dondelinger, F. & Wang, D. Looking beyond the hype: applied AI and machine learning in translational medicine. EBioMedicine 47, 607–615 (2019).
Clarke, R. et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat. Rev. Cancer 8, 37–49 (2008).
Altman, N. & Krzywinski, M. The curse(s) of dimensionality. Nat. Methods 15, 399–400 (2018).
Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).
Leek, J. T. svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 42, e161 (2014).
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
Kobak, D. & Berens, P. The art of using t-SNE for single-cell transcriptomics. Nat. Commun. 10, 5416 (2019).
Dorrity, M. W., Saunders, L. M., Queitsch, C., Fields, S. & Trapnell, C. Dimensionality reduction by UMAP to visualize physical and genetic interactions. Nat. Commun. 11, 1537 (2020).
Chellappa, R. & Turaga, P. Feature selection. In Computer Vision: a Reference Guide 1–5 (Springer International, 2020).
Chen, C.-H., Härdle, W. & Unwin, A. Handbook of Data Visualization (Springer, 2008).
Jolliffe, I. T. & Cadima, J. Principal component analysis: a review and recent developments. Philos. Trans. A Math. Phys. Eng. Sci. 374, 20150202 (2016).
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at arXiv https://doi.org/10.48550/arXiv.1802.03426 (2018).
Nguyen, L. H. & Holmes, S. Ten quick tips for effective dimensionality reduction. PLoS Comput. Biol. 15, e1006907 (2019).
Wattenberg, M., Viégas, F. & Johnson, I. How to use t-SNE effectively. Distill 1, https://doi.org/10.23915/distill.00002 (2016).
Way, G. P., Zietz, M., Rubinetti, V., Himmelstein, D. S. & Greene, C. S. Compressing gene expression data using multiple latent space dimensionalities learns complementary biological representations. Genome Biol. 21, 109 (2020).
de Souto, M. C. P., Costa, I. G., de Araujo, D. S. A., Ludermir, T. B. & Schliep, A. Clustering cancer gene expression data: a comparative study. BMC Bioinformatics 9, 497 (2008).
Kothari, S. et al. Removing batch effects from histopathological images for enhanced cancer diagnosis. IEEE J. Biomed. Health Inform. 18, 765–772 (2014).
Dwivedi, S. K., Tjärnberg, A., Tegnér, J. & Gustafsson, M. Deriving disease modules from the compressed transcriptional space embedded in a deep autoencoder. Nat. Commun. 11, 856 (2020).
Fertig, E. J., Ding, J., Favorov, A. V., Parmigiani, G. & Ochs, M. F. CoGAPS: an R/C++ package to identify patterns and biological process activity in transcriptomic data. Bioinformatics 26, 2792–2793 (2010).
Quellec, G., Lamard, M., Conze, P.-H., Massin, P. & Cochener, B. Automatic detection of rare pathologies in fundus photographs using few-shot learning. Med. Image Anal. 61, 101660 (2020).
Arvaniti, E. & Claassen, M. Sensitive detection of rare disease-associated cell subsets via representation learning. Nat. Commun. 8, 14825 (2017).
Chaabane, I., Guermazi, R. & Hammami, M. Enhancing techniques for learning decision trees from imbalanced data. Adv. Data Anal. Classif. 14, 677–745 (2020).
Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001).
Köpcke, F. et al. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data. BMC Med. Inform. Decis. Mak. 13, 134 (2013).
Banerjee, J. et al. Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1. Genes 11, 226 (2020).
Colbaugh, R., Glass, K., Rudolf, C., & Tremblay, M. Learning to identify rare disease patients from electronic health records. AMIA Annu. Symp. Proc. 2018, 340–347 (2018).
Heiselet, B., Serre, T., Pontil, M. & Poggio, T. Component-based face detection. In Proceedings of the 2001 IEEE Computer Society Conference on Computer Vision and Pattern Recognition I (CPRV, 2001).
Kasinski, A. & Schmidt, A. The architecture of the face and eyes detection system based on cascade classifiers. In Computer Recognition Systems 2 (ed. Kurzynski, M. et al.) 124–131 (Springer, 2007).
Mikolov, T., Chen, K., Corrado, G. & Dean, J. Efficient estimation of word representations in vector space. Preprint at arXiv https://doi.org/10.48550/arXiv.1301.3781 (2013).
Han, S., Williamson, B. D. & Fong, Y. Improving random forest predictions in small datasets from two-phase sampling designs. BMC Med. Inform. Decis. Mak. 21, 322 (2021).
Ambert, K. H. & Cohen, A. M. A system for classifying disease comorbidity status from medical discharge summaries using automated hotspot and negated concept detection. J. Am. Med. Inform. Assoc. 16, 590–595 (2009).
Chawla, N. V., Bowyer, K. W., Hall, L. O. & Kegelmeyer, W. P. SMOTE: synthetic minority over-sampling technique. J. Artif. Intell. Res. 16, 321–357 (2002).
More, A. Survey of resampling techniques for improving classification performance in unbalanced datasets. Preprint at arXiv https://doi.org/10.48550/arXiv.1608.06048 (2016).
Goodfellow, I., Bengio, Y. & Courville, A. Deep Learning (MIT, 2016).
Futoma, J., Simons, M., Doshi-Velez, F. & Kamaleswaran, R. Generalization in clinical prediction models: the blessing and curse of measurement indicator variables. Crit. Care Explor. 3, e0453 (2021).
Okser, S. et al. Regularized machine learning in the genetic prediction of complex traits. PLoS Genet. 10, e1004754 (2014).
Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. B Stat. Methodol. 67, 301–320 (2005).
Founta, K. et al. Gene targeting in amyotrophic lateral sclerosis using causality-based feature selection and machine learning. Mol. Med. 29, 12 (2023).
Torang, A., Gupta, P. & Klinke, D. J. 2nd An elastic-net logistic regression approach to generate classifiers and gene signatures for types of immune cells and T helper cell subsets. BMC Bioinformatics 20, 433 (2019).
Dincer, A. B., Celik, S., Hiranuma, N. & Lee, S.-I. DeepProfile: deep learning of cancer molecular profiles for precision medicine. Preprint at bioRxiv https://doi.org/10.1101/278739 (2018).
Kingma, D. P. & Welling, M. Auto-encoding variational Bayes. Preprint at arXiv https://doi.org/10.48550/arXiv.1312.6114 (2013).
Sánchez Fernández, I. et al. Deep learning in rare disease. Detection of tubers in tuberous sclerosis complex. PLoS ONE 15, e0232376 (2020).
Mungall, C. J. et al. The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res. 45, D712–D722 (2017).
Himmelstein, D. S. et al. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife 6, e26726 (2017).
Callahan, T. J., Tripodi, I. J., Hunter, L. E. & Baumgartner, W. A. A framework for automated construction of heterogeneous large-scale biomedical knowledge graphs. Preprint at bioRxiv https://doi.org/10.1101/2020.04.30.071407 (2020).
Percha, B. & Altman, R. B. A global network of biomedical relationships derived from text. Bioinformatics 34, 2614–2624 (2018).
Orphanet https://www.orpha.net/consor/cgi-bin/index.php (2023).
Queralt-Rosinach, N. et al. Structured reviews for data and knowledge-driven research. Database 2020, baaa015 (2020).
Moon, C. et al. Learning drug–disease–target embedding (DDTE) from knowledge graphs to inform drug repurposing hypotheses. J. Biomed. Inform. 119, 103838 (2021).
Li, X. et al. Improving rare disease classification using imperfect knowledge graph. BMC Med. Inform. Decis. Mak. 19, 238 (2019).
Sosa, D. N. et al. A literature-based knowledge graph embedding method for identifying drug repurposing opportunities in rare diseases. In Biocomputing 2020 463–474 (World Scientific, 2019).
Shen, F. et al. Rare disease knowledge enrichment through a data-driven approach. BMC Med. Inform. Decis. Mak. 19, 32 (2019).
Rao, A. et al. Phenotype-driven gene prioritization for rare diseases using graph convolution on heterogeneous networks. BMC Med. Genomics 11, 57 (2018).
Köhler, S. et al. The Human Phenotype Ontology in 2021. Nucleic Acids Res. 49, D1207–D1217 (2021).
Rolland, T. et al. A proteome-scale map of the human interactome network. Cell 159, 1212–1226 (2014).
Martens, M. et al. WikiPathways: connecting communities. Nucleic Acids Res. 49, D613–D621 (2021).
Pan, S. J. & Yang, Q. A survey on transfer learning. IEEE Trans. Knowl. Data Eng. 22, 1345–1359 (2010).
Lee, S.-I. et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat. Commun. 9, 42 (2018).
Mao, W., Zaslavsky, E., Hartmann, B. M., Sealfon, S. C. & Chikina, M. Pathway-level information extractor (PLIER) for gene expression data. Nat. Methods 16, 607–610 (2019).
Taroni, J. N. et al. MultiPLIER: a transfer learning framework for transcriptomics reveals systemic features of rare disease. Cell Syst. 8, 380–394 (2019).
Greene, D., NIHR BioResource, Richardson, S. & Turro, E. Phenotype similarity regression for identifying the genetic determinants of rare diseases. Am. J. Hum. Genet. 98, 490–499 (2016).
Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82–93 (2011).
Ionita-Laza, I., Capanu, M., De Rubeis, S., McCallum, K. & Buxbaum, J. D. Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autism. PLoS Genet. 10, e1004729 (2014).
Greene, D., NIHR BioResource, Richardson, S. & Turro, E. A fast association test for identifying pathogenic variants involved in rare diseases. Am. J. Hum. Genet. 101, 104–114 (2017).
Boycott, K. M., Vanstone, M. R., Bulman, D. E. & MacKenzie, A. E. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 14, 681–691 (2013).
Wright, C. F., FitzPatrick, D. R. & Firth, H. V. Paediatric genomics: diagnosing rare disease in children. Nat. Rev. Genet. 19, 253–268 (2018).
Adams, D. R. & Eng, C. M. Next-generation sequencing to diagnose suspected genetic disorders. N. Engl. J. Med. 379, 1353–1362 (2018).
Byrd, J. B., Greene, A. C., Prasad, D. V., Jiang, X. & Greene, C. S. Responsible, practical genomic data sharing that accelerates research. Nat. Rev. Genet. 21, 615–629 (2020).
Rieke, N. et al. The future of digital health with federated learning. NPJ Digit. Med. 3, 119 (2020).
Yan, Y. et al. A continuously benchmarked and crowdsourced challenge for rapid development and evaluation of models to predict COVID-19 diagnosis and hospitalization. JAMA Netw. Open 4, e2124946 (2021).
Lundberg, S. M. et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat. Biomed. Eng. 2, 749–760 (2018).
Zhou, G., Zhang, J., Su, J., Shen, D. & Tan, C. Recognizing names in biomedical texts: a machine learning approach. Bioinformatics 20, 1178–1190 (2004).
Blitzer, J., McDonald, R. & Pereira, F. Domain adaptation with structural correspondence learning. In Proceedings of the 2006 Conference on Empirical Methods in Natural Language Processing (eds. Jurafsky, D. & Gaussier, E.) 120–128 (Association for Computational Linguistics, 2006).
Wang, C. & Mahadevan, S. Heterogeneous domain adaptation using manifold alignment. In Proceedings of the Twenty-Second International Joint Conference on Artificial Intelligence 2 (ed. Walsh, T.) 1541–1546 (AAAI, 2011).
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
Collado-Torres, L. et al. Reproducible RNA-seq analysis using recount2. Nat. Biotechnol. 35, 319–321 (2017).
Kuhn, M. & Johnson, K. Applied Predictive Modeling (Springer, 2013).
Davis, J. & Goadrich, M. The relationship between precision–recall and ROC curves. In Proceedings of the 23rd International Conference on Machine Learning (eds. Cohen, W. W. & Moore, A.) 233–240 (Association for Computing Machinery, 2006).
Hastie, T., Friedman, J. & Tibshirani, R. The Elements of Statistical Learning (Springer, 2001).
Shin, H.-C. et al. Deep convolutional neural networks for computer-aided detection: CNN architectures, dataset characteristics and transfer learning. IEEE Trans. Med. Imaging 35, 1285–1298 (2016).
Acknowledgements
This work was supported in part by Alex’s Lemonade Stand Foundation, the National Human Genome Research Institute (R01 HG010067), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD109765), the Neurofibromatosis Therapeutic Acceleration Program, the Children’s Tumor Foundation and the Gilbert Family Foundation.
Author information
Authors and Affiliations
Contributions
Authorship was determined using ICMJE recommendations. Conceptualization: J.B., J.N.T., R.J.A., C.G., J.G; data curation: not applicable; formal analysis: not applicable; funding acquisition: R.J.A.; investigation: J.B., J.N.T., R.J.A.; methodology: J.B., J.N.T., R.J.A.; project administration: J.B.; resources: J.B., J.N.T., R.J.A.; software: not applicable; supervision: J.B., C.G.; validation: not applicable; visualization: D.V.P.; writing (original draft): J.B., J.N.T., R.J.A.; writing (review and editing): J.B., J.N.T., R.J.A., C.G., J.G.
Corresponding author
Ethics declarations
Competing interests
J.G. is currently employed at Tempus Labs, a precision medicine company. J.N.T. and D.V.P. are employed with Alex’s Lemonade Stand Foundation, a research funder. The remaining authors declare no competing interests.
Peer review
Peer review information
Nature Methods thanks Pejman Mohammadi and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Lin Tang, in collaboration with the Nature Methods team.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Banerjee, J., Taroni, J.N., Allaway, R.J. et al. Machine learning in rare disease. Nat Methods 20, 803–814 (2023). https://doi.org/10.1038/s41592-023-01886-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41592-023-01886-z